A composition for use as an antiobestic agent and preventive or therapeutic agent for diabetes, containing a compound of the formula (I): ##STR1##

wherein, A is substituted aryl or substituted heteroaryl with one or more group(s); (here, one of following groups is at least contained as the substituent: —RA—RB (RA is S, SO, SO2, NRC, NRCSO2 (RC is hydrogen or lower alkyl) or lower alkylene); RB is optionally substituted aryl);

    • X is O, S, NR wherein R is hydrogen or lower alkyl, or single bond;
    • m is an integer of 0 to 4;
    • n is an integer of 1 to 6
    • p is an integer of 1 to 3,
    • pharmaceutically acceptable salt, prodrug or hydrate thereof.
  •  
    Web www.patentalert.com

    < Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof

    < Intron/exon structure of the human and mouse 3-adrenergic receptor genes

    > Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion

    > Potassium channel interacting polypeptides and uses thereof

    ~ 00210